@mmhhpp I just had a quick read through of it. To be honest I've met better second hand car salesman. I'm dyslexic but he manages make me look good!

@mmhhpp - Please do not take this as a personal criticism This is an excellent example of crap that floats around on the Internet, but looks legit. 1 - it is a 'report' generated by a company whose entire business model is in selling reports of highly questionable quality to wannabe investors. 2 - no decent brokerage/fund worth its salt buys this sort of thing, they have in-house expertise. 3 - there is zero medical input. It was compiled by a researcher whose biggest boast in his bio is that he 'worked as a research analyst with a big equity company'. Really, a big name would be mentioned. It is like saying you went to a University near to Harvard. Prob a community college. 4 - it is taking an exclusively financial opportunity view. Usually looking to recommend undervalued shares to buy early (heaven forbid the small firms ever tried to influence these reports, only a cynic would suggest that) as investing in parma research is a very risky field, fraught with danger. Promising companies can often go pop overnight if a drug fails at any stage in trial. The aim of the company flogging the free sample is only to try and hook you in to buy the whole report and preferably to subscribe to reports. They are quite underhand. request the sample (use a different email) and watch how fast they are all over you trying to sign you up with deals. They have no value or credibility - despite how they try and sound - regarding a medical/patient type of view. I'd hazard a guess that they rehashed much of the MS-SMART trial output - read here http://www.ms-smart.org/ or go to http://solo.bodleian.ox.ac.uk/primo-explore/fulldisplay?docid=TN_whiterose134134&context=PC&vid=SOLO&lang=en_US&search_scope=LSCOP_ALL&adaptor=primo_central_multiple_fe&tab=local&query=any,contains,SPMS%20drugs&sortby=rank&offset=0 for the abstract unless you have academic library access. This is all about interrogating the source of the information, understanding their agenda and motivations as well as all about and CoI - conflicts of interest - they may have! I have written about this here: https://theproblemwithdata.com/2018/12/10/how-do-i-know/ Skip to Section 2 Best, Dominic